Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Zambetti

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Tumori|August 31, 1987
Aminoglutethimide in postmenopausal breast cancer refractory to multiple hormonal and cytostatic treatmentsM Zambetti, C Brambilla, G Tancini, et al.
Tumori|April 30, 1989
Mitomycin C and vinblastine in advanced refractory breast cancerC Brambilla, M Zambetti, L Ferrari, et al.
Tumori|March 1, 1997
Role of bone scan in breast cancer follow-upL Maffioli, M Zambetti, M R Castellani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1993
Lack of bone marrow toxicity of high-dose cyclophosphamide associated with inefficient drug metabolismM Zucchetti, M Zambetti, J M Hartley, et al.
Gynecologic Oncology|March 1, 1990
cis-platinum/vinblastine/bleomycin combination chemotherapy in advanced or recurrent granulosa cell tumors of the ovaryM Zambetti, A Escobedo, S Pilotti, et al.
The New England Journal of Medicine|April 6, 1995
Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-upG Bonadonna, P Valagussa, A Moliterni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1991
Cyclophosphamide, methotrexate, and fluorouracil with and without doxorubicin in the adjuvant treatment of resectable breast cancer with one to three positive axillary nodesA Moliterni, G Bonadonna, P Valagussa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1994
Second malignancies following CMF-based adjuvant chemotherapy in resectable breast cancerP Valagussa, A Moliterni, M Terenziani, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1988
Hormonal changes induced by the pure antiandrogen flutamide in postmenopausal women with advanced breast cancerG Secreto, C Recchione, M Zambetti, et al.
Journal of the National Cancer Institute|January 5, 1994
Local recurrences following mastectomy: support for the concept of tumor dormancyR Demicheli, M Terenziani, P Valagussa, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Tumori|August 31, 1987
Aminoglutethimide in postmenopausal breast cancer refractory to multiple hormonal and cytostatic treatmentsM Zambetti, C Brambilla, G Tancini, et al.
Tumori|April 30, 1989
Mitomycin C and vinblastine in advanced refractory breast cancerC Brambilla, M Zambetti, L Ferrari, et al.
Tumori|March 1, 1997
Role of bone scan in breast cancer follow-upL Maffioli, M Zambetti, M R Castellani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1993
Lack of bone marrow toxicity of high-dose cyclophosphamide associated with inefficient drug metabolismM Zucchetti, M Zambetti, J M Hartley, et al.
Gynecologic Oncology|March 1, 1990
cis-platinum/vinblastine/bleomycin combination chemotherapy in advanced or recurrent granulosa cell tumors of the ovaryM Zambetti, A Escobedo, S Pilotti, et al.
The New England Journal of Medicine|April 6, 1995
Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-upG Bonadonna, P Valagussa, A Moliterni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1991
Cyclophosphamide, methotrexate, and fluorouracil with and without doxorubicin in the adjuvant treatment of resectable breast cancer with one to three positive axillary nodesA Moliterni, G Bonadonna, P Valagussa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1994
Second malignancies following CMF-based adjuvant chemotherapy in resectable breast cancerP Valagussa, A Moliterni, M Terenziani, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1988
Hormonal changes induced by the pure antiandrogen flutamide in postmenopausal women with advanced breast cancerG Secreto, C Recchione, M Zambetti, et al.
Journal of the National Cancer Institute|January 5, 1994
Local recurrences following mastectomy: support for the concept of tumor dormancyR Demicheli, M Terenziani, P Valagussa, et al.
Pageof 5